Cart
sales@molnova.com
D3-βArr
CAS No. 662164-09-2
D3-βArr( NCGC00379308 )
Catalog No. M20139 CAS No. 662164-09-2
D3-βArr is a positive allosteric modulator for thyrotropin receptor (TSHR) which initiates translocation of β-Arr 1 (EC50: 11.6 μM) by direct TSHR activation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 50 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 176 | In Stock |
|
| 50MG | 329 | In Stock |
|
| 100MG | 501 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameD3-βArr
-
NoteResearch use only, not for human use.
-
Brief DescriptionD3-βArr is a positive allosteric modulator for thyrotropin receptor (TSHR) which initiates translocation of β-Arr 1 (EC50: 11.6 μM) by direct TSHR activation.
-
DescriptionD3-βArr is a positive allosteric modulator for thyrotropin receptor (TSHR) which initiates translocation of β-Arr 1 (EC50: 11.6 μM) by direct TSHR activation.
-
In Vitro——
-
In Vivo——
-
SynonymsNCGC00379308
-
PathwayOthers
-
TargetOther Targets
-
Recptorthyrotropin receptor (TSHR)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number662164-09-2
-
Formula Weight333.43
-
Molecular FormulaC20H23N5
-
Purity>98% (HPLC)
-
SolubilityDMSO: 100 mg/mL (299.91 mM)
-
SMILESCC(Nc1nc(nc2ccccc12)N1CCNCC1)c1ccccc1
-
Chemical NameN-(1-Phenylethyl)-2-(1-piperazinyl)-4-quinazolinamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Neumann S et al. Discovery of a Positive Allosteric Modulator of the Thyrotropin Receptor: Potentiation of Thyrotropin-Mediated Preosteoblast Differentiation In Vitro. J Pharmacol Exp Ther. 2018 Jan;364(1):38-45.
molnova catalog
related products
-
Cadralazine
Cadralazine is a peripheral arteriolar vasodilator and can be used in studies about acting as an antihypertensive drug.
-
TN1
TN1 is a potent inducer of fetal hemoglobin (HbF).
-
Exoticin
Exoticin shows antinociceptive and neuropharmacological activities, it could be considered as a suitable candidate for the development of analgesic and anxiolytic agents.
